Ibandronate in the treatment of postmenopausal osteoporosis: A cost-effectiveness analysis in the UK

被引：0
|
作者：
Earnshaw, S.
Lynch, N. O.
Cowell, W.
Beard, S.
机构：
[1] Roche Pharmaceut, London, England
[2] RTI Hlth Solut, Manchester, Lancs, England
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2006年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：416 / 416
页数：1
相关论文
共 50 条
  • [1] The cost-effectiveness of ibandronate in the treatment of postmenopausal osteoporosis in the US
    Earnshaw, SR
    Graham, CN
    Amonkar, MM
    Barr, CE
    VALUE IN HEALTH, 2006, 9 (03) : A163 - A163
  • [2] Cost-effectiveness of Ibandronate injection in the treatment of US women with postmenopausal osteoporosis.
    Earnshaw, Stephanie R.
    Graham, Christopher N.
    Amonkar, Mayur M.
    Barr, Charles E.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S584 - S584
  • [3] Cost-effectiveness of ibandronate injection IV in the treatment of UK women with postmenopausal osteoporosis who are intolerant to oral bisphosphonates
    Lynch, N. O.
    Earnshaw, S. R.
    Graham, C. N.
    Middelhoven, H.
    OSTEOPOROSIS INTERNATIONAL, 2007, 18 : S11 - S12
  • [4] Cost-effectiveness of parathyroid hormone in the treatment of osteoporosis in postmenopausal women in the UK
    Lundkvist, J
    Jonssson, L
    Johnell, O
    Sykes, D
    OSTEOPOROSIS INTERNATIONAL, 2003, 14 : S11 - S11
  • [5] Cost-effectiveness of Denosumab for the treatment of postmenopausal osteoporosis
    B. Jönsson
    O. Ström
    J. A. Eisman
    A. Papaioannou
    E. S. Siris
    A. Tosteson
    J. A. Kanis
    Osteoporosis International, 2011, 22 : 967 - 982
  • [6] Cost-effectiveness of Denosumab for the treatment of postmenopausal osteoporosis
    Jonsson, B.
    Strom, O.
    Eisman, J. A.
    Papaioannou, A.
    Siris, E. S.
    Tosteson, A.
    Kanis, J. A.
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 (03) : 967 - 982
  • [7] COST-EFFECTIVENESS OF DENOSUMAB IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS IN SCOTLAND
    Davies, A.
    Compston, J.
    Ferguson, S.
    McClosky, E.
    Shearer, A.
    Taylor, A.
    VALUE IN HEALTH, 2011, 14 (07) : A310 - A310
  • [8] Comment on: cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis
    B. Jönsson
    O. Ström
    J. A. Eisman
    A. Papaioannou
    E. S. Siris
    A. Tosteson
    J. A. Kanis
    Osteoporosis International, 2012, 23 : 2063 - 2065
  • [9] COST-EFFECTIVENESS OF ABALOPARATIDE FOR THE TREATMENT OF POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS
    Hiligsmann, M.
    Williams, S. A.
    Fitzpatrick, L. A.
    Reginster, J. -Y.
    OSTEOPOROSIS INTERNATIONAL, 2018, 29 : S50 - S51
  • [10] Cost-effectiveness of Denosumab for the Treatment of Postmenopausal Osteoporosis in Malaysia
    Choo, Y. W.
    Mohd Tahir, N. A.
    Mohamed Said, M. S.
    Li, S. C.
    Makmor Bakry, M.
    OSTEOPOROSIS INTERNATIONAL, 2022, 33 (09) : 1909 - 1923
12345